BRIEF published on 07/24/2026 at 10:01, 3 months 16 days ago BlackRock Inc. réduit sa participation dans IPSEN SA Droits De Vote Franchissement De Seuil Actions BlackRock Ipsen SA
PRESS RELEASE published on 07/24/2026 at 09:56, 3 months 16 days ago Franchissement de seuil BlackRock Inc. declares crossing below 5% threshold in IPSEN SA capital and voting rights on July 6, 2026 Déclaration BlackRock Inc. Threshold Crossing Ipsen SA Capital Decrease
BRIEF published on 07/24/2026 at 07:05, 3 months 16 days ago Mise à jour sur l'essai BOLD de phase III d'Ipsen dans l'atrésie des voies biliaires Recherche Clinique Odevixibat Atrésie Des Voies Biliaires Essai BOLD De Phase III Transplantation Hépatique
BRIEF published on 07/24/2026 at 07:05, 3 months 16 days ago Update on Ipsen's Phase III BOLD Trial in Biliary Atresia Clinical Research Biliary Atresia Phase III BOLD Trial Odevixibat Liver Transplantation
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 16 days ago Ipsen fait le point sur l'essai de Phase III BOLD dans l'atrésie des voies biliaires Ipsen annonce que l'essai de Phase III BOLD pour l'atrésie des voies biliaires n'a pas atteint son critère principal. Les données confirment le profil de sécurité de l'odévixibat Ipsen Essai De Phase III Odevixibat Atrésie Des Voies Biliaires BOLD
PRESS RELEASE published on 07/24/2026 at 07:00, 3 months 16 days ago Ipsen provides update on Phase III BOLD trial in biliary atresia Ipsen's Phase III BOLD trial for biliary atresia did not meet primary endpoint. Bylvay safety profile confirmed. Insights gained will aid future research and patient care Ipsen Biliary Atresia Phase III BOLD Trial Bylvay Pediatric Liver Transplant
BRIEF published on 07/09/2026 at 07:05, 4 months ago Résultats Positifs en Phase III pour Dysport® dans le Traitement de la Migraine Phase III Dysport Migraine Épisodique Migraine Chronique Toxine Botulinique
BRIEF published on 07/09/2026 at 07:05, 4 months ago Dysport® Achieves Milestone in Migraine Phase III Trials Phase III Trials Dysport Episodic Migraine Chronic Migraine Botulinum Toxin
BRIEF published on 07/09/2026 at 07:05, 4 months ago Dysport® franchit une étape importante dans les essais de phase III sur la migraine Essais De Phase III Dysport Migraine Épisodique Migraine Chronique Toxine Botulique
BRIEF published on 07/09/2026 at 07:05, 4 months ago Positive Phase III Results for Dysport® in the Treatment of Migraine Phase III Dysport Episodic Migraine Chronic Migraine Botulinum Toxin
Published on 11/10/2026 at 02:45, 2 hours 9 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 5 hours 44 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 5 hours 54 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 6 hours 22 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 6 hours 39 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 01:20, 3 hours 34 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 22:54, 6 hours ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 6 hours 44 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 6 hours 49 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 18:30, 10 hours 24 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 10 hours 24 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 11 hours 9 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 11 hours 9 minutes ago Déclaration des droits de vote à fin octobre 2026
